Skip to content
10-Q

Quarterly Report

IRIS BIOTECHNOLOGIES INC

0001554795-16-000678

← back to feed
Filed
May 13, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2016 · May 13, 2016 19.77M sh
Operating Cash Flow Q1 2016 · Mar 31, 2016 −$78.62K
Operating Cash Flow Q1 2016 · Mar 31, 2015 −$140.79K
Cash And Equivalents Q1 2016 · Mar 31, 2016 $10.22K
Cash And Equivalents Q1 2016 · Dec 31, 2015 $19.84K
Cash And Equivalents Q1 2016 · Mar 31, 2015 $179.1K
Cash And Equivalents Q1 2016 · Dec 31, 2014 $322.93K
Stockholders Equity Q1 2016 · Mar 31, 2016 −$357.89K
Stockholders Equity Q1 2016 · Dec 31, 2015 −$441.5K
Current Liabilities Q1 2016 · Mar 31, 2016 $370.57K
Current Liabilities Q1 2016 · Dec 31, 2015 $468.58K
Total Liabilities Q1 2016 · Mar 31, 2016 $396.57K
Total Liabilities Q1 2016 · Dec 31, 2015 $494.58K
Current Assets Q1 2016 · Mar 31, 2016 $11.12K
Current Assets Q1 2016 · Dec 31, 2015 $23.46K
Total Assets Q1 2016 · Mar 31, 2016 $38.69K
Total Assets Q1 2016 · Dec 31, 2015 $53.08K
Sga Expense Q1 2016 · Mar 31, 2016 $145.59K
Sga Expense Q1 2016 · Mar 31, 2015 $257.22K
Rd Expense Q1 2016 · Mar 31, 2016 $37.54K
Rd Expense Q1 2016 · Mar 31, 2015 $21.6K
Net Income Q1 2016 · Mar 31, 2016 −$473.61K
Net Income Q1 2016 · Mar 31, 2015 −$280.21K
Operating Income Q1 2016 · Mar 31, 2016 −$185.19K
Operating Income Q1 2016 · Mar 31, 2015 −$279.64K
Capex Q1 2016 · Mar 31, 2015 $3.04K